Bjw. Evans et al., RANDOMIZED DOUBLE-MASKED PLACEBO-CONTROLLED TRIAL OF A TREATMENT FOR CONGENITAL NYSTAGMUS, Vision research (Oxford), 38(14), 1998, pp. 2193-2202
Several therapies have been developed for congenital nystagmus (CN) bu
t without placebo-controlled trials. We investigated a treatment which
combined two therapies that had been advocated by several authors and
were reported to improve visual acuity (VA). A placebo treatment was
designed to mimic the time, attention,'high tech' apparatus, and the e
xplanation used in the experimental treatment. To each group, 38 subje
cts with CN were randomly allocated. Their VA and contrast sensitivity
(CS) were assessed three times before undergoing treatment for 6 week
s and then once more. An improvement in VA occurred, however, this was
not significantly different in the two groups. The improvement in CS
was greater in the experimental than in the control group, but the dif
ference failed to reach significance in most statistical tests. We con
clude that putative therapies for CN should be assumed to be placebos
until proven otherwise with randomized controlled trials. (C) 1998 Els
evier Science Ltd. All rights reserved.